SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN)

262 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q3 2021.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 217 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 54,377,202 shares of 56,047,431 outstanding shares and own 97.02% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8,858,737 shares), VANGUARD GROUP INC (5,477,743 shares), ARMISTICE CAPITAL, LLC (3,900,000 shares), DIMENSIONAL FUND ADVISORS LP (2,275,051 shares), MACQUARIE GROUP LTD (2,137,071 shares), STATE STREET CORP (1,827,841 shares), LOOMIS SAYLES & CO L P (1,650,567 shares), GW&K Investment Management, LLC (1,625,490 shares), RENAISSANCE TECHNOLOGIES LLC (1,388,622 shares), and Aristotle Capital Boston, LLC (1,318,109 shares).
This table shows the top 217 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.